Filing Flows › Innospec (IOSP) › Q3 2026 › vs Q2 2026
Innospec (IOSP) Q3 2026 vs Q2 2026 (quarter over quarter)
Innospec's revenue fell $17.8M (-4%) from $491M in Q2 2026 to $474M in Q3 2026. Gross margin 27.3% against 28.1% (-0.9 pts).
Innospec, Q3 2026: revenue $474M (+7% year over year), operating margin 8.8%, net earnings $31.6M, operating cash flow $17.4M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 27.3% | 28.1% | -0.9 pts |
| Operating margin | 8.8% | 8.1% | +0.7 pts |
| Net margin | 6.7% | 6.3% | +0.3 pts |
| Free cash flow margin | 0.3% | -2.1% | +2.5 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $474M | $491M | −$17.8M | -4% |
| Gross profit | $129M | $138M | −$9.2M | -7% |
| Cost of revenue | $344M | $353M | −$8.6M | -2% |
| Operating profit | $41.7M | $39.7M | $2.0M | +5% |
| Operating expenses | $87.4M | $98.6M | −$11.2M | -11% |
| Pre-tax earnings | $42.6M | $41.6M | $1.0M | +2% |
| Net earnings | $31.6M | $31.2M | $400K | +1% |
| Income tax | $11.0M | $10.4M | $600K | +6% |
| Depreciation & amortization | $9.6M | $10.0M | −$400K | -4% |
| Share-based compensation | $1.4M | $2.2M | −$800K | -36% |
| Working capital & other | $25.2M | $36.2M | −$11.0M | -30% |
| Operating cash flow | $17.4M | $7.2M | $10.2M | +142% |
| Free cash flow (OCF − capex) | $1.6M | −$10.5M | $12.1M | — |
| Capital expenditures | $15.8M | $17.7M | −$1.9M | -11% |
Questions
How much did Innospec's revenue grow quarter over quarter in Q3 2026?
Innospec's revenue fell $17.8M (-4%) from $491M in Q2 2026 to $474M in Q3 2026. Gross margin 27.3% against 28.1% (-0.9 pts).